Similar articles

• Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.

  Amiot A, Setakhr V, Seksik P, Allez M, Treton X, De Vos M, Laharie D, Colombel JF, Abitbol V, Reimund JM, Moreau J, Veyrac M, Flourié B, Cosnes J, Lemann M, Bouhnik Y. Amiot A, et al. Am J Gastroenterol. 2014 Sep;109(9):1443-9. doi: 10.1038/ajg.2014.183. Epub 2014 Aug 5. Am J Gastroenterol. 2014. PMID: 25091063
• Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease.

  Vaughan D, Drumm B. Vaughan D, et al. N Engl J Med. 1999 Jan 21;340(3):239-40. doi: 10.1056/NEJM199901213400317. N Engl J Med. 1999. PMID: 9917236 No abstract available.
• Complete resolution of enterocolic fistulas with infliximab.

  Nunes J, Santos PM, Tavares L. Nunes J, et al. BioDrugs. 2010 Dec 14;24 Suppl 1:28-30. doi: 10.2165/11586260-000000000-00000. BioDrugs. 2010. PMID: 21175233
• [Optimizing treatment of complicated forms of inflammatory bowel disease. Fistulizing Crohn's disease].

  Peñate M, Cruz-Santamaría M, Mendoza JL, Peña AS, Díaz-Rubio M, García-Paredes J. Peñate M, et al. An Med Interna. 2003 Jan;20(1):37-45. An Med Interna. 2003. PMID: 12666309 Review. Spanish. No abstract available.
• [Enteral fistulas in Crohn disease].

  Muller C. Muller C. Schweiz Rundsch Med Prax. 1984 Nov 27;73(48):1477-87. Schweiz Rundsch Med Prax. 1984. PMID: 6440262 Review. German. No abstract available.